Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US7022830B2 · kind B2 · utility
8Cited by
58References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 26, 2002 |
| Grant date | Apr 4, 2006 |
| Priority date | — |
| Expiry date | Jul 27, 2023 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Aspects of the present invention relate to the discovery of a novel hepatitis C virus (HCV) isolate. Embodiments include HCV peptides, nucleic acids encoding said HCV peptides, antibodies directed to said peptides, compositions containing said nucleic acids and peptides, as well as methods of making and using the aforementioned compositions including, but not limited to, diagnostics and medicaments for the treatment and prevention of HCV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.